Tobam decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 7.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,436 shares of the healthcare product maker’s stock after selling 652 shares during the period. Tobam’s holdings in Abbott Laboratories were worth $959,000 at the […]

Hollencrest Capital Management reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 69.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,561 shares of the healthcare product maker’s stock after selling 3,516 shares during the period. Hollencrest […]

Kesler Norman & Wride LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 54,508 shares of the healthcare product maker’s stock after selling 302 shares during the […]

Veracity Capital LLC lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 10.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,801 shares of the healthcare product maker’s stock after purchasing an additional 458 shares during the period. Veracity Capital LLC’s holdings in Abbott […]